Asset Planning Services Inc Pfizer Inc Transaction History

Asset Planning Services Inc

$202 Million
Q3 2024

A detailed history of Asset Planning Services Inc transactions in Pfizer Inc stock. As of the latest transaction made, Asset Planning Services Inc holds 116,635 shares of PFE stock, worth $3.24 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares

116,635

Previous 119,230 2.18%

Holding current value

$3.24 Million

Previous $3.34 Million 1.17%

% of portfolio

1.67%

Previous 1.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $71,881 - $81,457	-2,595 Reduced 2.18%	116,635 $3.38 Million
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $143,350 - $167,980	-5,675 Reduced 4.54%	119,230 $3.34 Million
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $6,524 - $7,491	252 Added 0.2%	124,905 $3.47 Million
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $20,904 - $27,152	-800 Reduced 0.64%	124,653 $3.59 Million
Q3 2023 Oct 19, 2023	BUY	$32.09 - $37.51 $108,303 - $126,596	3,375 Added 2.76%	125,453 $4.16 Million
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $56,166 - $64,983	-1,555 Reduced 1.26%	122,078 $4.48 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $31,905 - $41,536	-810 Reduced 0.65%	123,633 $5.04 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $47,386 - $61,857	-1,135 Reduced 0.9%	124,443 $6.38 Million
Q3 2022 Oct 19, 2022	SELL	$43.76 - $53.42 $13,128 - $16,026	-300 Reduced 0.24%	125,578 $5.5 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $15,122 - $17,930	-325 Reduced 0.26%	125,878 $6.6 Million
Q1 2022 Apr 22, 2022	BUY	$45.75 - $56.69 $49,410 - $61,225	1,080 Added 0.86%	126,203 $6.53 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $50,823 - $75,337	-1,230 Reduced 0.97%	125,123 $7.39 Million
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $35,325 - $45,378	-900 Reduced 0.71%	126,353 $5.43 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $52,428 - $59,392	1,460 Added 1.16%	127,253 $4.98 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $97,388 - $109,835	-2,908 Reduced 2.26%	125,793 $4.56 Million
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $5,689 - $7,235	170 Added 0.13%	128,701 $4.74 Million
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $66,040 - $77,480	-2,080 Reduced 1.59%	128,531 $4.72 Million
Q2 2020 Jul 14, 2020	BUY	$30.12 - $36.54 $82,528 - $100,119	2,740 Added 2.14%	130,611 $4.27 Million
Q1 2020 Apr 16, 2020	BUY	$27.03 - $38.62 $5,406 - $7,723	200 Added 0.16%	127,871 $4.17 Million
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $18,106 - $20,548	-550 Reduced 0.43%	127,671 $5 Million
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $37,850 - $49,081	-1,165 Reduced 0.9%	128,221 $4.61 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $68,413 - $76,812	1,850 Added 1.45%	129,386 $5.61 Million
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $13,125 - $14,420	350 Added 0.28%	127,536 $5.42 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $10,579 - $12,061	275 Added 0.22%	127,186 $5.55 Million
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $39,640 - $48,081	1,150 Added 0.91%	126,911 $0
Q2 2018 Jul 17, 2018	BUY	$32.98 - $35.16 $126,643 - $135,014	3,840 Added 3.15%	125,761 $4.56 Million
Q1 2018 Apr 17, 2018	BUY	$31.91 - $37.02 $65,415 - $75,891	2,050 Added 1.71%	121,921 $4.33 Million
Q4 2017 Jan 25, 2018	BUY	$33.26 - $35.29 $71,509 - $75,873	2,150 Added 1.83%	119,871 $4.34 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $119,350 - $131,477	3,850 Added 3.38%	117,721 $4.2 Million
Q2 2017 Aug 08, 2017	BUY	N/A	113,871	113,871 $3.83 Million

Others Institutions Holding PFE

# of Institutions

3,244

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Planning Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Asset Planning Services Inc with notifications on news.

Account

Asset Planning Services Inc Pfizer Inc Transaction History